We thank Harold Pupko for raising several relevant points concerning our article.1 Valproate-induced hyperammonemic encephalopathy is a well- described phenomenon, but its precise incidence is unknown ...

South Asia is expected to register a 4.2% CAGR with regard to hyperammonemia treatment disbursement By treatment type, glycerol phenylbutyrate is estimated to account for a segment share of 35.5% by ...